Home » Stocks » OXFD

Oxford Immunotec Global PLC (OXFD)

Stock Price: $13.85 USD 0.17 (1.24%)
Updated November 24, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 359.57M
Revenue (ttm) 57.30M
Net Income (ttm) -17.48M
Shares Out 25.96M
EPS (ttm) -0.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 24
Last Price $13.85
Previous Close $13.68
Change ($) 0.17
Change (%) 1.24%
Day's Open 13.84
Day's Range 13.70 - 14.27
Day's Volume 53,628
52-Week Range 8.37 - 17.77

More Stats

Market Cap 359.57M
Enterprise Value 207.53M
Earnings Date (est) Mar 2, 2021
Ex-Dividend Date n/a
Shares Outstanding 25.96M
Float 25.37M
EPS (basic) -0.67
EPS (diluted) -0.67
FCF / Share -0.68
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 378,133
Short Ratio 2.49
Short % of Float 1.49%
Beta 1.29
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.28
PB Ratio 1.86
Revenue 57.30M
Operating Income -18.06M
Net Income -17.48M
Free Cash Flow -17.48M
Net Cash 152.04M
Net Cash / Share 5.86
Gross Margin 94.98%
Operating Margin -31.52%
Profit Margin -30.50%
FCF Margin -30.51%
ROA -4.99%
ROE -8.19%
ROIC -45.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$18.25*
(31.77% upside)
Low
16.0
Current: $13.85
High
21.0
Target: 18.25
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue73.7159.7554.7346.9962.7849.5138.7820.6912.64
Revenue Growth23.36%9.17%16.48%-25.16%26.82%27.64%87.5%63.63%-
Gross Profit54.4242.9336.2630.5033.2425.5020.188.264.22
Operating Income-6.12-20.72-57.40-26.41-23.97-21.79-7.35-12.93-13.32
Net Income-1.81121-32.89-22.35-24.48-22.17-8.66-14.88-13.10
Shares Outstanding26.5725.9823.7622.3521.7817.313.831.761.22
Earnings Per Share-0.074.58-1.38-1.00-1.12-1.28-2.26-8.44-10.78
Operating Cash Flow-7.16-17.39-3.57-21.91-16.55-20.78-5.62-14.37-12.66
Capital Expenditures-1.66-5.35-1.30-0.86-3.39-3.01-1.79-1.48-1.24
Free Cash Flow-8.82-22.74-4.87-22.77-19.94-23.79-7.41-15.85-13.90
Cash & Equivalents18119390.3359.1183.7250.3776.5812.97-
Total Debt8.690.1929.9329.690.470.590.731.77-
Net Cash / Debt17319360.4029.4383.2549.7775.8511.20-
Assets23523214412411073.8592.7425.48-
Liabilities21.5618.1156.6151.0517.1613.2411.998.53-
Book Value21421487.6372.9692.6960.6180.7516.95-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Oxford Immunotec Global PLC
Country United Kingdom
Employees 273
CEO Peter James Wrighton-Smith

Stock Information

Ticker Symbol OXFD
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: OXFD
IPO Date November 22, 2013

Description

Oxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.